80 related articles for article (PubMed ID: 3545877)
1. Quantity and nature of residual bone marrow T cells after treatment of the marrow with Campath-1.
Irlé C; Kaestli M; Aapro M; Chapuis B; Jeannet M
Exp Hematol; 1987 Feb; 15(2):163-70. PubMed ID: 3545877
[TBL] [Abstract][Full Text] [Related]
2. T-cell depletion of Cercopithecus aethiops monkey bone marrow with Campath-1 monoclonal antibody and complement.
Phan DT; Barta E; Gidáli J; Fehér I; Harsányi V; Petrányi GG; Hollán SR
Haematologia (Budap); 1987; 20(3):155-63. PubMed ID: 3500899
[TBL] [Abstract][Full Text] [Related]
3. [Quantitative determination of human bone marrow T cells following in vitro depletion by Campath-1 monoclonal antibody].
Irlé C; Kaestli M; Chapuis B; Jeannet M
Schweiz Med Wochenschr; 1985 Oct; 115(43):1517-8. PubMed ID: 3909385
[TBL] [Abstract][Full Text] [Related]
4. Optimal conditions for in vitro T cell depletion of human bone marrow by Campath-1a plus complement as demonstrated by limiting dilution analysis.
Frame JN; Sheehy D; Cartagena T; Cirrincione C; O'Reilly RJ; Dupont B; Kernan NA
Bone Marrow Transplant; 1989 Jan; 4(1):55-61. PubMed ID: 2784335
[TBL] [Abstract][Full Text] [Related]
5. Cercopithecus aethiops monkey as a reliable model for in vitro study of T cell depletion of bone marrow with Campath-1 plus complement.
Phan DT; Benczur M; Gidáli J; Fehér I; Harsányi V; Nemes L; Petrányi G; Hollán SR
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(1):97-106. PubMed ID: 2472335
[TBL] [Abstract][Full Text] [Related]
6. [The effect of Campath-1 on T- and NK-cells].
Schofer O; Veit BC; Johnson FL
Immun Infekt; 1988 Aug; 16(4):143-7. PubMed ID: 3263310
[TBL] [Abstract][Full Text] [Related]
7. Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood.
Van Epps DE; Bender J; Lee W; Schilling M; Smith A; Smith S; Unverzagt K; Law P; Burgess J
Blood Cells; 1994; 20(2-3):411-23. PubMed ID: 7538347
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
[TBL] [Abstract][Full Text] [Related]
9. Purging of T-lymphocytes with magnetic affinity colloid.
Yau JC; Reading CL; Thomas MW; Davaraj BM; Tindle SE; Jagannath S; Dicke KA
Exp Hematol; 1990 Mar; 18(3):219-22. PubMed ID: 2303117
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal rat anti-human lymphocyte antibody Campath-1 binds to T and B lymphocytes but effectively lyses only T cells.
Gazitt Y; Or R; Mumcuoglu M; Slavin S
Bone Marrow Transplant; 1987 Dec; 2(4):427-33. PubMed ID: 3332190
[TBL] [Abstract][Full Text] [Related]
11. Detection of residual T-cells in T-cell depleted bone marrow: a comparison of immunofluorescence and limiting dilution culture techniques.
Williamson IK; Dickinson AM; Proctor SJ
Med Lab Sci; 1989 Apr; 46(2):127-34. PubMed ID: 2687607
[TBL] [Abstract][Full Text] [Related]
12. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
Li JM; Waller EK
Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
[TBL] [Abstract][Full Text] [Related]
13. [Effect of T-cell depletion of the graft on graft survival and graft vs host disease].
Irlé C; Aapro M; Chapuis B; Kaestli M; Marin P; Jeannet M
Schweiz Med Wochenschr; 1986 Nov; 116(48):1685-6. PubMed ID: 3492041
[TBL] [Abstract][Full Text] [Related]
14. Use of limiting dilution analysis to assess residual T cell content in human marrow after treatment with monoclonal anti-T cell antibody and complement.
Cooley MA; Thornton M; Wong KL; Atkinson K; Biggs J
Transplant Proc; 1986 Apr; 18(2):337-9. PubMed ID: 3485845
[No Abstract] [Full Text] [Related]
15. Comparison of efficiency of complements from various species for T-cell depletion from Cercopithecus aethiops bone marrow with Campath-1 MoAb in vitro.
Phan DT; Gidáli J; Fehér I; Harsányi V; Petrányi GG; Hollán SR
Haematologia (Budap); 1987; 20(4):203-13. PubMed ID: 3501389
[TBL] [Abstract][Full Text] [Related]
16. Effects of CD34+ selection and T cell immunodepletion on cord blood hematopoietic progenitors: relevance to stem cell transplantation.
Laver J; Traycoff CM; Abdel-Mageed A; Gee A; Lee C; Turner C; Srour EF; Abboud M
Exp Hematol; 1995 Dec; 23(14):1492-6. PubMed ID: 8542936
[TBL] [Abstract][Full Text] [Related]
17. Depletion of T cells from human bone marrow with monoclonal antibody CT-2 and complement.
Trigg ME; Billing R; Sondel PM; Dickerman JD; Erickson C; Finlay JL; Bozdech M; Hong R; Padilla-Nash H; Terasaki P
J Biol Response Mod; 1984 Aug; 3(4):406-12. PubMed ID: 6384432
[TBL] [Abstract][Full Text] [Related]
18. Depletion of T cells from bone marrow for allogeneic transplantation: method for treatment of bone marrow in bulk.
Trigg ME; Peterson A; Erickson C; Bozdech M; Billing R; Sondel P; Finlay J; Surfus J; Stuiber M; Hong R
Exp Hematol; 1986 Jan; 14(1):21-6. PubMed ID: 3080322
[TBL] [Abstract][Full Text] [Related]
19. Cellular immunoabsorption using monoclonal antibodies. Selective removal of T cells from peripheral blood and bone marrow.
Berenson RJ; Levitt LJ; Levy R; Miller RA
Transplantation; 1984 Aug; 38(2):136-42. PubMed ID: 6380041
[TBL] [Abstract][Full Text] [Related]
20. Comparison of three techniques for the ex vivo elimination of T cells from human bone marrow.
Blazar BR; Quinones RR; Heinitz KJ; Sevenich EA; Filipovich AH
Exp Hematol; 1985 Feb; 13(2):123-8. PubMed ID: 3882442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
